Position history for NewEdge Advisors, LLC's holdings in CUE BIOPHARMA INC
NewEdge Advisors, LLC holds 20,000 shares of CUE (CUE BIOPHARMA INC), worth $20,000 as of 2026-Q1. CUE represents 0.0% of NewEdge Advisors, LLC's portfolio.
Current Value
$20,000
Current Shares
20,000
Total Value Change
+$16,838
Total Shares Change
+17,450
Other major holders of CUE: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
Unchanged |
| 20,000 |
0.0% |
| $20,000 |
| 0.0% |
| $0.30 |
0 |
| 2025-Q4 | Unchanged | 20,000 | 0.0% | $6,108 | 0.0% | $0.30 | 0 |
| 2025-Q3 | Unchanged | 20,000 | 0.0% | $14,374 | 0.0% | $0.72 | 0 |
| 2025-Q2 | Increased | 20,000 | +684.3% | $13,646 | 0.0% | $0.74 | 29 |
| 2025-Q1 | Unchanged | 2,550 | 0.0% | $2,323 | 0.0% | $0.92 | 0 |
| 2024-Q4 | Unchanged | 2,550 | 0.0% | $2,780 | 0.0% | $1.02 | 0 |
| 2024-Q3 | Unchanged | 2,550 | 0.0% | $1,931 | 0.0% | $0.68 | 0 |
| 2024-Q2 | New | 2,550 | - | $3,162 | 0.0% | $1.24 | 20 |